View in EDS

Safety, immunogenicity, and relative efficacy of a parenteral trivalent rotavirus subunit vaccine candidate (TV P2-VP8) in healthy Ghanaian, Malawian, and Zambian infants.

Saved in:
Bibliographic Details
Title: Safety, immunogenicity, and relative efficacy of a parenteral trivalent rotavirus subunit vaccine candidate (TV P2-VP8) in healthy Ghanaian, Malawian, and Zambian infants.
Authors: Tewari T; PATH, India. Electronic address: ttewari@path.org., Armah G; Noguchi Memorial Institute for Medical Research, Ghana., Cunliffe NA; University of Liverpool, United Kingdom., Chisenga CC; Centre for Infectious Disease Research in Zambia, Zambia., Witte D; University of Liverpool, United Kingdom; Malawi Liverpool Wellcome Research Programme (MLW), Malawi., Kukula V; Dodowa Health Research Centre, Ghana., Jere KC; University of Liverpool, United Kingdom; Malawi Liverpool Wellcome Research Programme (MLW), Malawi; Kamuzu University of Health Sciences, Malawi., Simuyandi M; Centre for Infectious Disease Research in Zambia, Zambia., Damanka S; Noguchi Memorial Institute for Medical Research, Ghana., Mwinjiwa E; Malawi Liverpool Wellcome Research Programme (MLW), Malawi., Kazimbaya K; Centre for Infectious Disease Research in Zambia, Zambia., Atuguba F; Dodowa Health Research Centre, Ghana., Williams J; Dodowa Health Research Centre, Ghana., Chilengi R; Centre for Infectious Disease Research in Zambia, Zambia., Csedrik J; PATH, USA., Gast C; PATH, USA., Fix A; PATH, USA., Cryz S; PATH, USA.
Source: Vaccine [Vaccine] 2026 Jan 05; Vol. 70, pp. 128019. Date of Electronic Publication: 2025 Nov 29.
Publication Type: Clinical Trial, Phase III; Equivalence Trial; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2025.128019